From: Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo
Parameter | Female | Male | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Control | TRC combination(g/kg, oral) | Control | TRC combination(g/kg, oral) | |||||||
0.5 | 1.08 | 2.32 | 5 | 0.5 | 1.08 | 2.32 | 5 | |||
Terminal body | 32.5 ± 1.24 | 31.40 ± 1.74 | 34.33 ± 1.53 | 31 ± 1.64 | 30.33 ± 0.57 | 39.25 ± 2.64 | 38.60 ± 2.40 | 39.00 ± 2.64 | 38.00 ± 2.35 | 39.67 ± 1.53 |
Brain(%) | 1.26 ± 0.16 | 1.32 ± 0.20 | 1.24 ± 0.23 | 1.60 ± 013 | 1.47 ± 0.08 | 1.15 ± 0.20 | 1.32 ± 0.20 | 1.09 ± 0.17 | 5.93 ± 0.08 | 1.15 ± 0.06 |
Heart(%) | 0.54 ± 0.04 | 0.54 ± 0.07 | 0.53 ± 0.06 | 0.56 ± 0.07 | 0.54 ± 0.02 | 0. 58 ± 0.05 | 0.59 ± 0.01 | 0.59 ± 0.08 | 0.58 ± 0.02 | 0.59 ± 0.08 |
Lung(%) | 0.88 ± 0.12 | 0.68 ± 0.06 | 1.04 ± 0.45 | 0.86 ± 0.17 | 0.75 ± 0.05 | 0.68 ± 0.04 | 0.78 ± 0.10 | 0.70 ± 0.05 | 0.67 ± 0.06 | 0.75 ± 0.05 |
Liver(%) | 5.12 ± 0.16 | 5.06 ± 0.14 | 5.11 ± 0.29 | 5.55 ± 0.63 | 4.97 ± 0.21 | 5.46 ± 0.14 | 5.60 ± 0.06 | 5.64 ± 0.12 | 5.74 ± 0.03 | 5.59 ± 0.20 |
Kidney(%) | 1.24 ± 0.06 | 1.26 ± 0.10 | 1.21 ± 0.06 | 1.34 ± 0.13 | 1.22 ± 0.02 | 1.64 ± 0.19 | 1.56 ± 0.21 | 1.60 ± 0.23 | 1.68 ± 0.14 | 1.54 ± 0.16 |
Spleen(%) | 0.39 ± 0.03 | 0.37 ± 0.01 | 0.39 ± 0.03 | 0.39 ± 0.05 | 0.39 ± 0.05 | 0.37 ± 0.03 | 0.37 ± 0.10 | 0.38 ± 0.03 | 0.35 ± 0.08 | 0.37 ± 0.04 |
testis | - | - | - | - | - | 0.51 ± 0.04 | 0.55 ± 0.06 | 0.55 ± 0.06 | 0.51 ± 0.05 | 0.51 ± 0.08 |